logo
Select company
Select metric
$ 224KNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
39
Sector
70
Industry
82
History
-
$ 2.09Close
$ 0.99 - $ 4.47 52-Week Range
Ticker Information

Ticker

MURA

Company Name

MURAL ONCOLOGY PLC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MURAL ONCOLOGY PLC - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MURA - CF - Equity Historical data
DateNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025$ 224K
3/31/2025$ 224K
12/31/2024$ 196K
9/30/2024$ 196K
6/30/2024$ 0
12/31/2023$ 0
12/31/2022$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MURAL ONCOLOGY PLC's latest trailing twelve months (TTM) CF - Equity stands at $ 0.
  • Over the past 5 years, MURAL ONCOLOGY PLC's average CF - Equity has been $ 120K.
  • The median CF - Equity for MURAL ONCOLOGY PLC during this period was $ 196K
  • MURAL ONCOLOGY PLC reached its highest CF - Equity over the past 5 years at $ 224K.
  • The lowest CF - Equity recorded by MURAL ONCOLOGY PLC in the same timeframe $ 0

Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).

MURA - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years

$ 0

Minimum

Dec 31, 2022

$ 224K

Maximum

Mar 31, 2025

$ 120K

Average

$ 196K

Median

CF - Equity Benchmark Analysis

The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 94.74K with a standard deviation of $ 17.64M.
The following table provides additional summary stats:
CF - Equity in the Market:
filtered constituents2.89K
min$ -60.59M
max$ 60.64M
average$ 94.74K
median$ 0
std$ 17.64M